- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05277441
A Novel Classification for the Assessment and Grading of Unexpected Events in Pediatric Surgery: The Clavien-Madadi Classification (ComPedS)
Postoperative adverse events may be associated with substantial morbidity and mortality. However, inconsistent definitions of complications and unexpected events have limited accurate analysis of surgical outcomes. In 2004, the Clavien-Dindo classification for postoperative complications has been introduced and has since then been validated in numerous studies, with more than 20.000 citations.
Despite the appraisal of the Clavien-Dindo classification in the pediatric surgical literature, some criticize the transfer of grading systems for adults into a pediatric cohort without modification or validation. In a recent study we have shown that few items of the classification do not offer relevant information in pediatric cohorts and we have added organizational and management errors, not integrated in the initial proposal by Dindo et al. Especially, the variety of options for the management of complications based on institutional protocols and logistics is emphasized and a more focused and detailed assessment of the invasiveness of procedures in children is introduced.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Omid Madadi-Sanjani, Dr
- Phone Number: +49-176-15329053
- Email: madadi-sanjani.omid@mh-hannover.de
Study Contact Backup
- Name: Joachim Kuebler, Dr
- Phone Number: +49-176-15329261
- Email: kuebler.joachim@mh-hannover.de
Study Locations
-
-
Lower Saxony
-
Hannover, Lower Saxony, Germany, 30625
- Recruiting
- Hannover Medical School
-
Contact:
- Omid Madadi-Sanjani
- Phone Number: +4917615329053
- Email: madadi-sanjani.omid@mh-hannover.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patients with unexpected events within the study period, treated at the department of pediatric surgery (preterms - 17 years of age), Hannover Medical School
Exclusion Criteria:
- None;
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of adverse events
Time Frame: Through study completion, an average of 3 years
|
Through study completion, an average of 3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Categorization of adverse events
Time Frame: Through study completion, an average of 3 years
|
Events associated with surgical/non-surgical interventions and events not associated with interventions such as organizational problems, management problems or underlying disease were differentiated.
|
Through study completion, an average of 3 years
|
|
Classification of adverse events
Time Frame: Through study completion, an average of 3 years
|
According to the Clavien-Dindo classification
|
Through study completion, an average of 3 years
|
|
Classification of adverse events using a novel instrument
Time Frame: Through study completion, an average of 3 years
|
According to the Clavien-Madadi classification
|
Through study completion, an average of 3 years
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9557_BO_K_2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.